Source: International Congress 2014 – More paediatric asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Stelmach, J. Jerzynska, K. Smejda (Lodz, Poland). Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab. Eur Respir J 2014; 44: Suppl. 58, 4222

Member's Comments

No comment yet.

Related content which might interest you: FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Identifying risk factors for bronchial asthma in children Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 Risk factors for poor asthma control in asthmatic children Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Asthma and rhinitis symptom score severity in children on SLIT Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Predictors factors for asthma in patients with rhinitis Source: International Congress 2014 – Clinical allergy Year: 2014 Sensitization to moulds in patients with newly diagnosed allergic asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Five-year clinical study of children with atopic asthma Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 Allergic rhinitis does it have an impact on controller asthma therapy choice Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 The effect of SLIT on asthma symptoms at different pediatric age ranges Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Influence of maternal bronchial asthma clinical phenotype on development of allergies in children Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Real life experience of omalizumab on selected children with severe allergic asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 An international comparison of eczema prevalence in infants, and the association with wheezing Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 Sensitization to three mites in Cuban children with allergic respiratory diseases Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Efficacy and safety of fluticasone propionate/formoterol in paediatric patients with asthma Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Tolerability and adherence to sublingual immunotherapy with mite vaccines with different schedule in asthmatic children Source: International Congress 2014 – More paediatric asthma Year: 2014 Bronchodilators in school children with asthma and normal FEV1 Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Asthma phenotypes in children: Allergic versus non allergic Source: International Congress 2016 – Living with asthma around the globe Year: 2016